Cell-culture studies by the Khavinson laboratory reported that the AEDG peptide (epitalon) activates telomerase and elongates telomeres in cultured human somatic cells.
Epithalon
Telomerase-activating peptide for longevity and cellular rejuvenation

Overview
Last reviewed: 2026-08-18
Identity & Aliases
Also known as
Status: Research compound - Telomerase activator
Full composition (formula, molecular weight, sequence) in Quick Facts →
Research Areas
Available Evidence
Clinical data are limited and come mainly from small Russian studies associated with the Khavinson group, reporting normalization of melatonin rhythm, improved sleep, immune parameters, and well-being in older adults; independent replication is largely lacking.
Animal studies (mice, rats, Drosophila) from the Khavinson laboratory report lifespan extension, normalization of pineal function, and reduced age-related pathology with the AEDG peptide (epithalon).
Cell-culture studies from the same group report that epithalon can activate telomerase and lengthen telomeres in cultured human somatic cells; these findings have not been independently reproduced.
The flagship claims - telomerase activation, telomere elongation, and human lifespan extension - rest almost entirely on a single research group's reports in Russian-language journals; no independent clinical confirmation exists.
Key Studies & Findings
Animal lifespan studies report that epithalon extends lifespan and normalizes age-related changes in pineal and immune function in mice and Drosophila.
Benefits & Effects
Telomerase activation
Telomere elongation (dose-dependent)
Hayflick limit extension: +10 extra cell divisions (44 vs 34 passages)
1.7-fold increase in melatonin metabolite excretion
Side Effects & Safety
No adverse effects documented; very limited human safety data
Limitations & Open Questions
Pharmacology
Reported Research Dosing
Reported values from research literature and community protocols. Educational reference only — not a dosing recommendation or medical advice.
5-10mg daily for 10 days
Research Protocols
Evidence-Based Protocol (Recommended)
- Dose
- 200-500μg
- Frequency
- Daily
- Route
- Subcutaneous
Conservative Start
- Dose
- 100μg
- Frequency
- Daily
- Route
- Subcutaneous
Russian Clinical Equivalent
- Dose
- 300μg
- Frequency
- Daily
- Route
- Subcutaneous
Traditional Western (Anecdotal)
- Dose
- 5-10mg
- Frequency
- Daily
- Route
- Subcutaneous
Ultra-Low Dose
- Dose
- 50μg
- Frequency
- Daily
- Route
- Subcutaneous
Research protocols are for educational purposes only. Always consult qualified medical professionals.
Frequently Asked Questions
Does epithalon really lengthen telomeres in humans?
Telomerase activation and telomere elongation were reported only in cell-culture studies from one Russian laboratory; there is no independent clinical evidence of telomere elongation in people.
Is epithalon approved anywhere?
It is not FDA approved; it has been used in Russia within the Khavinson bioregulator research and clinical practice.
Are the longevity claims evidence-based?
Animal lifespan studies by the originating lab exist, but independent replication and large human trials are lacking, so human longevity claims remain unproven.
Research Citations
Anisimov VN, Khavinson VKh, Alimova IN, Semchenko AV, Yashin AI (2002)
Khavinson VKh, Bondarev IE, Butyugov AA (2003)
Anisimov VN, Khavinsov VKh, Alimova IN, Provintsiali M, Manchini R, Francheski K (2002)
Khavinson VKh, Egorova VV, Timofeeva NM, Malinin VV, Gordova LA, Gromova LV (2002)
+ 21 more citations
Related Resources
Quick Facts
Formula
C14H22N4O9
Molecular Weight
390.35
Sequence
AEDG
Mechanism
Telomerase activator for cellular longevity
Safety Information
Research compound only. Limited human safety data available.
Citations
26Anisimov VN, Khavinson VKh, Alimova IN, Semchenko AV, Yashin AI (2002)
Khavinson VKh, Bondarev IE, Butyugov AA (2003)
Anisimov VN, Khavinsov VKh, Alimova IN, Provintsiali M, Manchini R, Francheski K (2002)
Khavinson VKh, Egorova VV, Timofeeva NM, Malinin VV, Gordova LA, Gromova LV (2002)
+ 21 more citations